CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker

被引：4
|
作者：
Li, Cuicui [1 ]
Zhang, Litian [1 ]
Jin, Qiqi [1 ]
Jiang, Haoyun [1 ]
Wu, Chongyang [1 ]
机构：
[1] Lanzhou Univ, Dept Gastroenterol, Hosp 2, Lanzhou 730000, Peoples R China
来源：
BIOMARKERS IN MEDICINE | 2023年 / 17卷 / 12期
基金：
中国国家自然科学基金;
关键词：
adenosine; biomarker; CD39; CD8(+) TIL; exhaustion; immunosuppression; PD-1; tumor microenvironment; CD8; T-CELLS; ECTONUCLEOTIDASES CD39; IMMUNE-RESPONSES; PD-L1; EXPRESSION; ADENOSINE; RECEPTOR; CD73; METABOLISM; SUBSETS; CANCER;
D O I：
10.2217/bmm-2023-0202
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
As a regulator of the dynamic balance between immune-activated extracellular ATP and immunosuppressive adenosine, CD39 ectonucleotidase impairs the ability of immune cells to exert anticancer immunity and plays an important role in the immune escape of tumor cells within the tumor microenvironment. In addition, CD39 has been studied in cancer patients to evaluate the prognosis, the efficacy of immunotherapy (e.g., PD-1 blockade) and the prediction of recurrence. This article reviews the importance of CD39 in tumor immunology, summarizes the preclinical evidence on targeting CD39 to treat tumors and focuses on the potential of CD39 as a biomarker to evaluate the prognosis and the response to immune checkpoint inhibitors in tumors.
引用
收藏
页码：563 / 576
页数：14
相关论文
共 50 条
  • [21] 海马CD39(ENTPD1)对小鼠抑郁样行为的影响及机制
    董婉婷
    胡壮丽
    陈建国
    中国药理学与毒理学杂志, 2021, 35 (09) : 694 - 694
  • [22] Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis
    Sonja Rothweiler
    Linda Feldbrügge
    Zhenghui Gordon Jiang
    Eva Csizmadia
    Maria Serena Longhi
    Kahini Vaid
    Keiichi Enjyoji
    Yury V. Popov
    Simon C. Robson
    Purinergic Signalling, 2019, 15 : 375 - 385
  • [23] ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis
    Braganhol, Elizandra
    de Andrade, Guilherme Pamplona Bueno
    Santos, Guilherme Tomasi
    Stefani, Marco Antonio
    PURINERGIC SIGNALLING, 2024, 20 (03) : 285 - 289
  • [24] SNP rs10748643 within the promoter region of ENTPD1 (the gene encoding CD39) has no prognostic value in Sezary patients
    Luo, Yixin
    Tensen, Kees
    Zoutman, Willem
    Najidh, Safa
    Quint, Koen
    Vermeer, Maarten
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S16 - S16
  • [25] ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis
    Stefani, Marco Antonio
    Braganhol, Elizandra
    Santos, Guilherme Tomasi
    Suwa, Samuel Masao
    Cabeleira, Daiane Dias
    de Andrade, Guilherme Pamplona Bueno
    PURINERGIC SIGNALLING, 2024,
  • [26] DELETION OF CD39/ENTPD1 UNVEILS MAJOR DIFFERENCES IN THE MECHANISMS UNDERLYING REJECTION OF TRANSPLANTED VS. GROWTH OF AUTOCHTHONOUS HEPATIC TUMORS
    Wu, Yan
    Sun, Xiaofeng
    Han, Lihui
    Usheva, Anny
    Csizmadia, Eva
    Robson, Simon C.
    HEPATOLOGY, 2010, 52 (04) : 603A - 603A
  • [27] Endothelial cell dysfunction in pulmonary artery hypertension is manifested with attenuated CD39/ENTPD1 activity in remodeled vessels
    Helenius, Mikko
    Vattulainen, Sanna
    Aho, Joonas
    Komulainen, Anne
    Taimen, Pekka
    Perez, Vinicio A. de Jesus
    Orcholski, Mark
    Koskenvuo, Juha W.
    Alastalo, Tero-Pekka
    PURINERGIC SIGNALLING, 2014, 10 (04) : 797 - 797
  • [28] Hippocampal CD39/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP
    Cui, Qian-Qian
    Hu, Zhuang-Li
    Hu, Yuan-Lang
    Chen, Xi
    Wang, Ji
    Mao, Li
    Lu, Xiao-Jia
    Ni, Ming
    Chen, Jian-Guo
    Wang, Fang
    EMBO REPORTS, 2020, 21 (04)
  • [29] Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/Entpd1 null Mice
    Sun, Xiaofeng
    Han, Lihui
    Seth, Pankaj
    Bian, Shu
    Li, Linglin
    Csizmadia, Eva
    Junger, Wolfgang G.
    Schmelzle, Moritz
    Usheva, Anny
    Tapper, Elliot B.
    Baffy, Gyorgy
    Sukhatme, Vikas P.
    Wu, Yan
    Robson, Simon C.
    HEPATOLOGY, 2013, 57 (01) : 205 - 216
  • [30] Reduced methylation downregulates CD39/ENTPD1 and ZDHHC14 to suppress trophoblast cell proliferation and invasion: Implications in preeclampsia
    Zhu, Lisha
    Lv, Ruitu
    Kong, Lingchun
    Li, Xiaotian
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2018, 14 : 59 - 67
12345